Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877)
:1877
Want to see HK:1877 full AI Analyst Report?
Comparison Results
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$27.54
HK$39.22B
-256.36
48.10%
3 Buy
0 Hold
0 Sell
Strong Buy
Zai Lab Ltd
HK$18.27
HK$17.16B
-9.51
-41.88%
7 Buy
0 Hold
0 Sell
Strong Buy
Alphamab Oncology
HK$11.90
HK$8.21B
-15.87
20.56%
1 Buy
0 Hold
0 Sell
Moderate Buy
RemeGen Co. Ltd. Class H
HK$119.90
HK$63.37B
36.25
109.89%
8 Buy
0 Hold
0 Sell
Strong Buy
Shanghai Henlius Biotech, Inc. Class H
HK$84.45
HK$38.32B
―
79.90%
6 Buy
0 Hold
0 Sell
Strong Buy
Ascentage Pharma Group International
HK$50.90
HK$13.91B
-6.78
-17.78%
2 Buy
0 Hold
0 Sell
Moderate Buy
Performance Comparison
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
22.60
6.92
44.13%
HK:9688
Zai Lab Ltd
14.56
-10.79
-42.56%
HK:9966
Alphamab Oncology
8.56
0.95
12.48%
HK:9995
RemeGen Co. Ltd. Class H
84.90
37.90
80.64%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
70.70
30.15
74.35%
HK:6855
Ascentage Pharma Group International
37.70
-6.55
-14.80%